Healthcare Services

4 stocks under daily watch in Healthcare Services. Each dossier is the cited public record of what credible sources reported.

This week on the record

Fortis Healthcare Limited stated it was a complete stranger to the legal dispute involving Daiichi Sankyo and the Singh Brothers and had no role in the alleged dissipation of the erstwhile promoters' shareholding.

Global Health has been allotted a land parcel measuring approximately 10,560 sq. metres at Siddharth Vihar Yojna, Ghaziabad, Uttar Pradesh, by the Uttar Pradesh Housing & Development Board for approximately Rs 165.82 crore on a freehold basis.

1 Oct 2026 · 3 publishers

The Supreme Court allowed a forensic audit of Fortis Healthcare to proceed, clarifying that the Delhi High Court's observations were solely for deciding the forensic audit issue.

28 Sep 2026 · 3 publishers

Hospital stocks, including Apollo Hospitals, Fortis Healthcare, and Krishna Institute of Medical Sciences (KIMS), fell up to 6% after the Supreme Court raised concerns over steep mark-ups on medicines sold through corporate hospitals.

30 Sep 2026 · 2 publishers

Lord's Mark Industries Limited has registered its haemodialysis system with the Medicines & Healthcare products Regulatory Agency (MHRA) in London, UK, enabling the launch of its AI-driven dialysis system and integrated renal-care ecosystem in UK and UK-allied markets.

29 Sep 2026 · 2 publishers

Sanofi Healthcare India purchased 35 lakh shares, amounting to a 15.19 per cent stake in Sanofi India for Rs 1,068.20 crore.

28 Sep 2026 · 2 publishers

This week on the record: 61 developments · 4 companies touched · 20 publishers

Coverage

Ticker	Company	Close (₹)	Change (%)
APOLLOHOSP	Apollo Hospitals Enterprise	₹8,133.50	▼ -0.39%
FORTIS	Fortis Healthcare	₹785.00	▲ +1.95%
MAXHEALTH	Max Healthcare Institute	₹940.95	▲ +1.20%
MEDANTA	Global Health	₹1,357.30	▼ -0.56%

All sectors →

Closes are the exchange's published end-of-day figures for their dated trading day. Evidence last checked 2 Oct 2026, 11:59 IST.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.